Recurrence rate in vulvar carcinoma in relation to pathological margin distance

International Journal of Gynecological Cancer

Volumn 20, Issue 5, 2010, Pages 869-873

  Groenen, Saskia M A ^a,c   Timmers, Petra J ^b   Burger, Curt W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Maasstad Hospital Rotterdam   (Netherlands)

^c IKAZIA HOSPITAL   (Netherlands)

Author keywords

Pathologic margin distance; Recurrence rate; Vulvar carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; BENIGN TUMOR; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; STROMA; VULVA CARCINOMA; VULVECTOMY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; VULVA; VULVAR NEOPLASMS;

EID: 77956806854     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGC.0b013e3181df7423     Document Type: Article

References (18)

1. Hacker NF. Vulvar Cancer. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005.
2. National Dutch Guideline Gynaecologic Tumors; Vulvar Carcinoma. 2008. Available at: Http://www.oncoline.nl. Accessed on July 1, 2008.
3. National Cancer Institute. Vulvar Cancer Treatment. National Institute of Health, U.S.; 2007. Available at http://www.cancer.gov. Accessed January 2009.
4. Woolderink JM, de Bock GH, de Hullu JA, et al. Patterns and frequency of recurrences of squamous cell carcinoma of the vulva. Gynecol Oncol. 2006;103:293Y299.
5. Chan JK, Sugiyama V, Pham H, et al. Margin distance and other clinico-pathologic prognostic factors in vulvar carcinoma: A multivariate analysis. Gynecol Oncol. 2007;104:636Y641.
6. Van der Zee AG, Oonk MH, De Hullu JA, et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol. 2008;26:884Y889.
7. DiSaia PJ, Creasman WT, Rich WM. An alternate approach to early cancer of the vulva. Am J Obstet Gynecol. 1979;133: 825Y832.
8. Hacker NF, Berek JS, Lagasse LD, et al. Individualization of treatment for stage I squamous cell vulvar carcinoma. Obstet Gynecol. 1984;63:155Y162.
9. Chan JK, Sugiyama V, Tajalli TR, et al. Conservative clitoral preservation surgery in the treatment of vulvar squamous cell carcinoma. Gynecol Oncol. 2004;95:152Y156.
10. Guideline Vulvar Carcinoma: Royal College of Obstetrics and Gynecology. 2006. Available at: Http://www.rcog.org.uk. Accessed January 2006.
11. Heaps JM, Fu YS, Montz FJ, et al. Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva. Gynecol Oncol. 1990;38:309Y314.
12. De Hullu JA, Hollema H, Lolkema S, et al. Vulvar carcinoma. The price of less radical surgery. Cancer. 2002;95:2331Y2338.
13. Rouzier R, Haddad B, Plantier F, et al. Local relapse in patients treated for squamous cell vulvar carcinoma: Incidence and prognostic value. Obstet Gynecol. 2002;100:1159Y1167.
14. Tantipalakorn C, Robertson G, Marsden DE, et al. Outcome and patterns of recurrence for International Federation of Gynecology and Obstetrics (FIGO) stages I and II squamous cell vulvar cancer. Obstet Gynecol. 2009;113:895Y901.
15. Homesley HD, Bundy BN, Sedlis A, et al. Prognostic factors for groin node metastasis in squamous cell carcinoma of the vulva (a Gynecologic Oncology Group study). Gynecol Oncol. 1993;49:279Y283.
16. Preti M, Ronco G, Ghiringhello B, et al. Recurrent squamous cell carcinoma of the vulva: Clinicopathologic determinants identifying low risk patients. Cancer. 2000;88:1869Y1876.
17. Maggino T, Landoni F, Sartori E, et al. Patterns of recurrence in patients with squamous cell carcinoma of the vulva. A multicenter CTF Study. Cancer. 2000;89:116Y122.
18. Stehman FB, Bundy BN, Ball H, et al. Sites of failure and times to failure in carcinoma of the vulva treated conservatively: A Gynecologic Oncology Group study. Am J Obstet Gynecol. 1996;174:1128Y1132; discussion 32Y33.